Terms of the offer
Wegovy 0.25mg FlexTouch promotes significant and lasting weight loss in adults who are obese (a BMI of 30 or higher) or overweight (a BMI of 27 or higher) with at least one co-existing condition like high blood pressure, type 2 diabetes, or deranged lipid levels. It works by mimicking natural hormones to enhance insulin secretion and regulate appetite. It supports weight management and overall health when combined with long-term lifestyle changes, including a reduced-calorie diet and regular ... Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, Wegovy is a once-weekly inject Wegovy solution for injection is a prescription medication used alongside a reduced-calorie diet and increased physical activity for long-term weight management. It is indicated for adults and adolescents (12+) with obesity, and for adults with overweight who have at least one weight-related health condition. For adults with known cardiovascular disease and either obesity or overweight, it also helps reduce the risk of major cardiovascular events (cardiovascular death, non-fatal heart attack ... What is Wegovy ®? WEGOVY ® (semaglutide) injection 2.4 mg is an injectable prescription medicine used with a reduced calorie diet and increased physical activity: to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight. that may help adults and children aged 12 years and older with obesity, or some adults with overweight who also have weight-related medical problems, to help them lose ...
